Branded medicines sales clawback cap
Statutory or agreed ceiling on revenue clawback rates applied to branded prescription medicine sales.
Unit Percent Industry Pharmaceuticals
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Branded medicines sales clawback cap
United Kingdom, as of 8 Sep 2026
Every record
All records
1 record · 1 region · 2026
| Period | Value | Source | Type |
|---|---|---|---|
| United Kingdom 1 record | |||
| as of 8 Sep 2026 | 15% | ABPI · 8 Sep 2026 | actual |
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Green shoots for UK pharma investment, but delivery will decide whether they take root | ABPI | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Branded medicines sales clawback cap. Retrieved from https://statorigin.org/indicators/branded-medicines-sales-clawback-cap